Paknezhad Seyedpouya, Serati Elaheh, Mehdizadeh Esfanjani Robab, Soleimanpour Maryam, Soleimanpour Hassan
Emergency and Trauma Care Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Anesth Pain Med. 2022 Nov 25;12(5):e131184. doi: 10.5812/aapm-131184. eCollection 2022 Oct.
One of the complications of laryngoscopy is cardiac dysrhythmia due to an increased QT interval.
This study aimed to compare the effect of fentanyl and remifentanil on QTc interval in patients undergoing intubation by the rapid method in 2020.
In this study, 50 patients without a history of heart disease and without a history of drug use who were candidates for rapid intubation in the emergency department were selected and divided into two groups. Before the injection of intubation drugs, a baseline ECG was obtained from the patient and then randomly assigned to one group of patients with 2 μg/kg fentanyl and the other group with 1 μg/kg remifentanil. Other intubation drugs, including lidocaine, etomidate, and succinylcholine, were fixed in both groups. Immediately after drug injection and immediately after laryngoscopy, ECG was prepared from patients, and the QT interval was calculated.
In group comparison, changes in QT values during the studied time were statistically significant (P = 0.004). However, in the comparison between groups, there was no statistically significant difference between the two groups receiving fentanyl and remifentanil (P = 0.235). The results showed that the rate of QT interval changes during three different measurements increased in both groups of patients receiving fentanyl and remifentanil.
In the present study, in comparing the QT interval, there was a statistically significant difference between the two groups receiving fentanyl and remifentanil at any of the studied times. Therefore, fentanyl and remifentanil during endotracheal intubation did not have a statistically and clinically significant effect on the QT distance of patients' ECG, and the administration of the above two drugs during intubation was safe.
喉镜检查的并发症之一是由于QT间期延长导致的心律失常。
本研究旨在比较2020年快速插管患者中芬太尼和瑞芬太尼对QTc间期的影响。
本研究选取了50例无心脏病史且无药物使用史、拟在急诊科进行快速插管的患者,并将其分为两组。在注射插管药物前,获取患者的基线心电图,然后随机将患者分为两组,一组给予2μg/kg芬太尼,另一组给予1μg/kg瑞芬太尼。两组的其他插管药物,包括利多卡因、依托咪酯和琥珀酰胆碱均固定。在药物注射后及喉镜检查后立即采集患者的心电图,并计算QT间期。
组间比较,研究期间QT值的变化具有统计学意义(P = 0.004)。然而,在两组之间的比较中,接受芬太尼和瑞芬太尼的两组之间没有统计学显著差异(P = 0.235)。结果显示,接受芬太尼和瑞芬太尼的两组患者在三次不同测量期间QT间期变化率均增加。
在本研究中,比较QT间期时,接受芬太尼和瑞芬太尼的两组在任何研究时间均无统计学显著差异。因此,气管插管期间芬太尼和瑞芬太尼对患者心电图的QT间期无统计学和临床显著影响,插管期间使用上述两种药物是安全的。